Procept BioRobotics [PRCT] vs Enovis [ENOV] Detailed Stock Comparison

Procept BioRobotics

NASDAQ
Loading...

Enovis

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Procept BioRobotics wins in 8 metrics, Enovis wins in 10 metrics, with 0 ties. Enovis appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricProcept BioRoboticsEnovisBetter
P/E Ratio (TTM)-19.85-2.04Procept BioRobotics
Price-to-Book Ratio5.140.67Enovis
Debt-to-Equity Ratio20.5756.75Procept BioRobotics
PEG Ratio0.66-0.02Enovis
EV/EBITDA-20.518.68Procept BioRobotics
Profit Margin (TTM)-30.60%-37.80%Procept BioRobotics
Operating Margin (TTM)-28.02%2.41%Enovis
EBITDA Margin (TTM)N/A2.41%N/A
Return on Equity-26.40%-28.25%Procept BioRobotics
Return on Assets (TTM)-12.93%0.89%Enovis
Free Cash Flow (TTM)$-103.62M$-67.21MEnovis
Dividend Yield0.64%N/AN/A
1-Year Return-52.11%-24.92%Enovis
Price-to-Sales Ratio (TTM)7.420.79Enovis
Enterprise Value$1.76B$3.15BEnovis
EV/Revenue Ratio6.411.44Enovis
Gross Profit Margin (TTM)65.35%59.29%Procept BioRobotics
Revenue per Share (TTM)$5$39Enovis
Earnings per Share (Diluted)$-1.50$-15.04Procept BioRobotics
Beta (Stock Volatility)1.031.79Procept BioRobotics
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Procept BioRobotics vs Enovis Stock Performance Analysis

Loading Price Chart...

Procept BioRobotics
Enovis
Procept BioRobotics Stock Overview | Enovis Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Procept BioRobotics0.20%-6.00%-12.05%-40.19%-39.73%-58.15%
Enovis0.30%1.77%-0.94%-8.70%-17.39%-31.04%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Procept BioRobotics-52.11%-13.09%-13.00%-13.00%-13.00%-13.00%
Enovis-24.92%-33.49%-44.86%-42.67%13.99%-13.41%

News Based Sentiment: Procept BioRobotics vs Enovis

Procept BioRobotics

News based Sentiment: MIXED

September presented a mixed bag for Procept BioRobotics, with strong Q2 earnings and positive analyst ratings countered by stock volatility, insider selling, and downward price target revisions. The conflicting signals create a complex investment picture, making it a significant month for the company's trajectory.

View Procept BioRobotics News Sentiment Analysis

Enovis

News based Sentiment: POSITIVE

October was a notably positive month for Enovis, marked by significant analyst upgrades, substantial insider buying activity, and a clear strategic direction under its new CEO. These developments suggest growing confidence in the company's future prospects and potential for growth, making it a significant month for investors.

View Enovis News Sentiment Analysis

Performance & Financial Health Analysis: Procept BioRobotics vs Enovis

MetricPRCTENOV
Market Information
Market Cap i$1.99B$1.74B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i902,800830,007
90 Day Avg. Volume i951,347931,692
Last Close$34.80$30.55
52 Week Range$34.01 - $103.81$25.47 - $49.83
% from 52W High-66.48%-38.69%
All-Time High$103.81 (Nov 11, 2024)$129.72 (Jun 09, 2014)
% from All-Time High-66.48%-76.45%
Growth Metrics
Quarterly Revenue Growth0.48%0.08%
Quarterly Earnings Growth0.48%0.08%
Financial Health
Profit Margin (TTM) i-0.31%-0.38%
Operating Margin (TTM) i-0.28%0.02%
Return on Equity (TTM) i-0.26%-0.28%
Debt to Equity (MRQ) i20.5756.75
Cash & Liquidity
Book Value per Share (MRQ)$6.94$45.11
Cash per Share (MRQ)$5.44$0.77
Operating Cash Flow (TTM) i$-83,214,000$188.06M
Levered Free Cash Flow (TTM) i$-59,140,124$65.68M
Dividends
Last 12-Month Dividend Yield i0.64%N/A
Last 12-Month Dividend i$0.38$0.00

Valuation & Enterprise Metrics Analysis: Procept BioRobotics vs Enovis

MetricPRCTENOV
Price Ratios
P/E Ratio (TTM) i-19.85-2.04
Forward P/E i-26.839.60
PEG Ratio i0.66-0.02
Price to Sales (TTM) i7.420.79
Price to Book (MRQ) i5.140.67
Market Capitalization
Market Capitalization i$1.99B$1.74B
Enterprise Value i$1.76B$3.15B
Enterprise Value Metrics
Enterprise to Revenue i6.411.44
Enterprise to EBITDA i-20.518.68
Risk & Other Metrics
Beta i1.031.79
Book Value per Share (MRQ) i$6.94$45.11

Financial Statements Comparison: Procept BioRobotics vs Enovis

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)PRCTENOV
Revenue/Sales i$69.16M$564.55M
Cost of Goods Sold i$25.00M$229.85M
Gross Profit i$44.16M$334.70M
Research & Development i$16.40M$30.70M
Operating Income (EBIT) i$-27.44M$-16.08M
EBITDA i$-22.39M$55.91M
Pre-Tax Income i$-24.74M$-25.65M
Income Tax iN/A$10.80M
Net Income (Profit) i$-24.74M$-36.55M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)PRCTENOV
Cash & Equivalents i$316.21M$38.46M
Total Current Assets i$465.79M$1.22B
Total Current Liabilities i$52.06M$477.42M
Long-Term Debt i$77.83M$1.42B
Total Shareholders Equity i$389.16M$2.62B
Retained Earnings i$-570.72M$-338.99M
Property, Plant & Equipment i$21.26M$492.24M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)PRCTENOV
Operating Cash Flow i$-11.65M$-1.07M
Capital Expenditures i$-1.84M$-43.26M
Free Cash Flow i$-18.82M$-44.86M
Debt Repayment iN/A$-15.44M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricPRCTENOV
Shares Short i8.15M6.93M
Short Ratio i8.527.31
Short % of Float i0.17%0.18%
Average Daily Volume (10 Day) i902,800830,007
Average Daily Volume (90 Day) i951,347931,692
Shares Outstanding i54.72M55.88M
Float Shares i53.56M56.42M
% Held by Insiders i0.05%0.02%
% Held by Institutions i0.98%1.21%

Dividend Analysis & Yield Comparison: Procept BioRobotics vs Enovis

MetricPRCTENOV
Last 12-Month Dividend i$0.38$0.00
Last 12-Month Dividend Yield i0.64%N/A
3-Year Avg Annual Dividend i$0.53$0.00
3-Year Avg Dividend Yield i0.12%N/A
3-Year Total Dividends i$1.59$0.00
Ex-Dividend DateMar 31, 2025N/A